DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report third-quarter fiscal 2014 results on July 25. The company will host a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
- Via webcast at Covidien’s website: http://investor.covidien.com
- By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-546-5021. For participants outside the U.S., the dial-in number is 857-244-7553. The access code for all callers is 44793724.
- Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. ET on July 25 and ending at 5 p.m. on August 1. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 61713038.
The company will issue a news release announcing financial results for the fiscal third quarter on July 25, prior to the conference call.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.